47045-PNG-T-WVI-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>PNG TB - Papua New Guinea (01-Apr-2015-31-Dec-2017)</narrative> Papua New Guinea, Tuberculosis, World Vision (PNG) Trust Goals: To ensure that high quality medicines are accessible and affordable to the entire population at all times and that they are used rationally (HSS); To establish and improve the quality of laboratory services with emphasis in Primary Health Care in Papua New Guinea (HSS); To reduce the estimated prevalence and death rates of TB to half their 1990 levels by 2020. This means reducing the est. prevalence rate to 339/ 100,000 population (or lower), and reducing the est. death rate to 30/100,000 population by 2020 (TB). Objectives: Improve PMDT in all the province focusing in 4 high MDRTB prevalent provinces by a) Increase percentage of previously treated TB patients receiving DST from 16% (2013) to 96% by 2020 and b) by achieving TSR for MDRTB from 14% (2011) to 60% by 2020 (TB); Improve the TB control program in the National Capital District (TB); Increase coverage of testing of TB patients for HIV from less than 25% (2013) to greater than 90% in 2020 focusing on 10 high HIV- burden provinces by strengthening TB HIV collaborative activities (TB); Strengthen the Implementation of the local PNG TB care and prevention strategy a) increase CNR for bacteriologically- confirmed, new and relapse cases, from 43 in 2013 to 93 per 100,000 population in 2020 and b) TSR from 68% in 2012 to 88% by 2020 (TB); To ensure adequate and continuous availability of safe, effective and good quality medicines to the entire population at all times (HSS); To ensure available medicines are safe, efficacious and of high quality (HSS); To ensure the quality of laboratory services performed meets accepted standards at all level of health facilities (HSS); To establish a coordinated national clinical and public health laboratory service in line with the National Health Service Standards that supports diagnosis, treatment, monitoring, surveillance and prevention of diseases (HSS). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust World Vision (PNG) Trust The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Sandra Irbe Fund Portfolio Manager +41 58 791 1700 sandra.irbe@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Papua New Guinea Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 6812650.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 1398153.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 1904630.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 1389357.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 7563551.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust -2120510.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 2371713.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 2013510.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 340899.14 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 100000.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 243950.37 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 1567700.49 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 12261.43 Funds returned to the Global Fund from PNG-T-WVIP01. World Vision (PNG) Trust The Global Fund to Fight AIDS, Tuberculosis and Malaria -12261.43 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust -925778.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 3433360.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 1220210.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 2163150.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 3135761.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust -50000.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 50000.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 901566.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 1357751.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust 50000.00 Global Fund disbursement to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust -876444.00 Global Fund commitment to PNG-T-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision (PNG) Trust <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 101. Numerator: 140. Numerator: 104. Numerator: 85. Numerator: 105. Numerator: 182. Numerator: 146. Numerator: 174. Numerator: 147. Numerator: 82; Denominator: 147; Percentage: 55.8%. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 102. Numerator: 126. Numerator: 94. Numerator: 103. Numerator: 94. Numerator: 165. Numerator: 131. Numerator: 132; Denominator: 131; Percentage: 100.8%. Numerator: 132. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 52; Denominator: 218. Numerator: 139; Denominator: 279. Numerator: 109; Denominator: 341. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 145; Denominator: 272. Numerator: 184; Denominator: 272. Numerator: 264; Denominator: 544. Numerator: 223; Denominator: 546. <narrative>HSS PSM-other 2: Number of sites that have mSupply (LMIS) installed and functioning</narrative> Module: RSSH: Health products management systems. <narrative>HSS PSM-other 2: Number of sites that have mSupply (LMIS) installed and functioning</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 1; Denominator: 34; Percentage: 2.9%. Numerator: 8. Numerator: 13. Numerator: 4. Numerator: 13. Numerator: 26; Denominator: 34; Percentage: 76.5%. <narrative>HSS SD-other 2: Percentage of laboratories showing adequate performance in external quality assurance for malaria microscopy among the total number of laboratories that undertake malaria microscopy during the reporting period</narrative> Module: RSSH: Integrated service delivery and quality improvement. <narrative>HSS SD-other 2: Percentage of laboratories showing adequate performance in external quality assurance for malaria microscopy among the total number of laboratories that undertake malaria microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 6; Denominator: 57. Numerator: 9; Denominator: 57. Numerator: 14; Denominator: 57. Numerator: 47; Denominator: 114. Numerator: 20; Denominator: 57. Numerator: 75; Denominator: 114. Numerator: 26; Denominator: 57. Numerator: 37; Denominator: 114. Numerator: 31; Denominator: 57. Numerator: 40; Denominator: 114. <narrative>HSS SD-other 3: Number and Percentage of functioning HIV testing sites participating in the EQA programme that meet the performance criteria</narrative> Module: RSSH: Integrated service delivery and quality improvement. <narrative>HSS SD-other 3: Number and Percentage of functioning HIV testing sites participating in the EQA programme that meet the performance criteria</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 17; Denominator: 55. Numerator: 22; Denominator: 55. Numerator: 25; Denominator: 55. Numerator: 25; Denominator: 126. Numerator: 28; Denominator: 55. Numerator: 19; Denominator: 63. Numerator: 30; Denominator: 55. Numerator: 28; Denominator: 63. Numerator: 33; Denominator: 55. Numerator: 88; Denominator: 120. <narrative>DOTS-other 1: Loss to follow up rate (LTFR) among all new bacteriologically confirmed TB cases (28 BMUs)</narrative> Module: TB care and prevention. <narrative>DOTS-other 1: Loss to follow up rate (LTFR) among all new bacteriologically confirmed TB cases (28 BMUs)</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 141; Denominator: 831. Numerator: 146; Denominator: 995. Numerator: 137; Denominator: 919. Numerator: 139; Denominator: 832. <narrative>DOTS-other 2: Smear not done rate among new pulmonary adult TB cases (28 BMUs)</narrative> Module: TB care and prevention. <narrative>DOTS-other 2: Smear not done rate among new pulmonary adult TB cases (28 BMUs)</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 678; Denominator: 2348. Numerator: 699; Denominator: 2366. Numerator: 863; Denominator: 2485. Numerator: 849; Denominator: 2500. <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative> Module: TB care and prevention. <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 12235. Numerator: 14906. Numerator: 7487. Numerator: 5920. Numerator: 7487. Numerator: 6125. Numerator: 7496. Numerator: 5919. Numerator: 7496. Numerator: 5883; Denominator: 7496; Percentage: 78.5%. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 22657. Numerator: 27603. Numerator: 13865. Numerator: 11822. Numerator: 13865. Numerator: 12964. Numerator: 13882. Numerator: 13541. Numerator: 13882. Numerator: 10837; Denominator: 13882; Percentage: 78.1%. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Module: TB care and prevention. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 3348. Numerator: 5146. Numerator: 3078. Numerator: 2120. Numerator: 3079. Numerator: 2181. Numerator: 3538. Numerator: 2015. Numerator: 3538. Numerator: 1662; Denominator: 3538; Percentage: 47%. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Module: TB care and prevention. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1285; Denominator: 1710. Numerator: 1494; Denominator: 2045. Numerator: 1543; Denominator: 2116. Numerator: 1148; Denominator: 1604. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 44; Denominator: 116. Numerator: 59; Denominator: 113. Numerator: 62; Denominator: 113. Numerator: 118; Denominator: 250. Numerator: 65; Denominator: 113. Numerator: 83; Denominator: 250. Numerator: 68; Denominator: 113. Numerator: 94; Denominator: 250. Numerator: 70; Denominator: 113. Numerator: 98; Denominator: 244. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 8404; Denominator: 12264. Numerator: 8525; Denominator: 13076. Numerator: 9086; Denominator: 13312. Numerator: 6963; Denominator: 10722. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 3175; Denominator: 5292. Numerator: 2057; Denominator: 2742. Numerator: 5741; Denominator: 6192. Numerator: 2057; Denominator: 2743. Numerator: 7308; Denominator: 7937. Numerator: 2397; Denominator: 2820. Numerator: 7343; Denominator: 8033. Numerator: 2398; Denominator: 2821. Numerator: 7842; Denominator: 8581. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 559; Denominator: 1300. Numerator: 444; Denominator: 808. Numerator: 247; Denominator: 401. Numerator: 445; Denominator: 809. Numerator: 317; Denominator: 353. Numerator: 638; Denominator: 967. Numerator: 326; Denominator: 381. Numerator: 638; Denominator: 967. Numerator: 308; Denominator: 320. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 8037; Denominator: 19603. Numerator: 4998; Denominator: 9801. Numerator: 4748; Denominator: 12733. Numerator: 4999; Denominator: 9802. Numerator: 4446; Denominator: 13921. Numerator: 5978; Denominator: 9801. Numerator: 5692; Denominator: 14069. Numerator: 5979; Denominator: 9802. Numerator: 5407; Denominator: 11487. <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 741; Denominator: 3704. Numerator: 768; Denominator: 1920. Numerator: 214; Denominator: 491. Numerator: 768; Denominator: 1920. Numerator: 530; Denominator: 6037. Numerator: 1184; Denominator: 1974. Numerator: 109; Denominator: 1022. Numerator: 1185; Denominator: 1975. Numerator: 46; Denominator: 662.